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SUMMARY
Hyperinsulinemia, diagnosed by laboratory tests, should be diagnosed and treated as soon as pos-
sible to prevent fatal complications such as neurological damage. Patients who are resistant to medi-
cal therapy should be treated surgically. Minimally invasive surgery, a newly developed approach, 
is a good choice among surgical procedures to avoid unnecessary extensive pancreatectomy. Here, 
a 12-year-old boy is presented with diagnosis of hyperinsulinemic hypoglycemia who had recur-
rent attacks of hypoglycemia and seizures from infancy. Because of his unresponsiveness to medical 
therapy and his family’s preference, he underwent laparoscopic pancreatectomy to reduce morbidity 
and hospital stay. Two years postsurgical follow-up revealed a normo-glycemic state. Arch Endocrinol 
Metab. 2015;59(5):466-9
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INTRODUCTION
P rimary persistent hyperinsulinemic hypoglycemia of infancy (PHHI), a rare inborn metabolic dis-
ease occurring due to excessive secretion of insulin, is 
diagnosed by glucose < 60 mg/dL in addition to el-
evated plasma insulin (> 2.0 pU/mL). Early diagnosis 
is important due to probable neurologic sequel, but it 
is the treatment that seems to be a matter of concern 
in medicine (1).
PHHI is categorized into focal and diffuse via dif-
ferent pathogeneses introduced (2,3). The treatment of 
choice for adenomatous hyperplasia of pancreatic cells, 
micro or macro adenoma, is surgical removal (4). On 
the contrary, diffuse hyperplasia, arisen by islet cell dys-
regulation of insulin production, can only be cured by 
near-total (95%) pancreatectomy as the initial procedure 
of choice when medical therapy has failed (5). Accord-
ing to probable postoperational problems, especially 
diabetes mellitus due to β-cell dysfunction (6), a biopsy 
is mandatory to distinguish the two forms of PHHI (7).
Minimally invasive procedures are used increasingly 
each year to minimize the invasion and side effects in 
various surgical procedures. Other advantages of mini-
mally invasive procedures include avoidance of large 
wounds, less postoperative pain, lower rate of morbid-
ity, earlier hospital discharge, and cosmetic benefits (8).
Here it is aimed to emphasize the importance of 
early diagnosis and the role of minimally invasive sur-
geries in the diagnosis and treatment of hyperinsulin-
emic status. 
CASE REPORT
The patient is a 12-year-old obese boy who was admit-
ted with recurrent hypoglycemic attacks followed by 
seizures and speech problems. During his first visit, his 
hallux was broken due to a recent trauma in a general-
ized tonic clonic seizure, and he had a bottle of sugary 
water in his hand, drinking every few minutes. His birth 
history was complicated by macrosomia and a birth 
weight of 5,200 g. His birth height was 60 cm. His 
mother was not diabetic, and he had no family history 
of documented hypoglycemia or any other inborn error 
of metabolism. In physical examination, his height was 
117.5 cm (2.5 z score), his weight was 30.2 kg (1.1 z 
score), and his body mass index was calculated at 27.27 
kg/m2. The examination revealed bilateral lipomastia 
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and pubertal tanner stage 1 both at gonadal and pubic 
stages. He was in the 5th grade with a good educational 
status, having never failed during his education. He had 
recurrent attacks of hypoglycemia from neonatal period 
that were diagnosed as PHHI and treated with 10 mg/kg 
diazoxide daily and frequent feeding. 
Hyperinsulinemia was confirmed in this patient by 
a fasting serum insulin of 9 pU/mL. He had low free 
fatty acids (both < 1.0 mmol/L), an inappropriate gly-
cemic response to intravenous glucagon (> 30 mg/dL 
rise in serum glucose level), and negative ketones in 
urine dipstick. Serum lactate, ammoniac, C-peptide, 
chromatography of serum amino acid and urine sug-
ars, morning cortisol, prolactin, and thyroid function 
tests were all normal (Table 1). Abdominal computered 
tomographic scan with intravenous and oral contrast 
did not reveal pancreatic adenoma. Due to his resis-
tance to medical therapy and his family’s decision, he 
was scheduled for surgical intervention. A laparoscopic 
biopsy was obtained, which revealed diffuse hyperpla-
sia of the pancreas; sections showed pancreatic tissue 
with normal acinar structure, intermixed with islets of 
Langerhans which are different in size and shape. The 
cells of the latter showed mild atypia characterized by 
vesicular nuclei with mild nuclear pleomorphism and 
enlargement, small nuclei and pale eosinophilic cyto-
plasm. No ductuloinsular complexes was identified in 
multiple sections examined (Figure 1). 
Table 1. The results of serum tests of the patient
Serum tests Patient’s result Reference value Unit Method Instrument
Fasting serum insulin 9 2.6-24.5 µIU/mL Electrochemiluminescency Elecsys 2010 Roche HITACHI
Lactate 4 2.5-20 mg/dL Colorimetric BT 3000
Ammoniac 26 Male: 25-94 Female: 
19-82
µg/dL Colorimetric BT 3000
C-peptide 2.5 0.8-3.1 ng/mL Electrochemiluminescency Elecsys 2010 Roche HITACHI
Chromatography of serum 
amino acids and 
Normal pattern - - HPLC Kenovera
Chromatography of urine 
sugars
Normal pattern - - TLC Kenovera
Morning cortisol 32 5-25 µg/dL Electrochemiluminescency Elecsys 2010 Roche HITACHI
Prolactin NL • Males: 2 - 18 
• Non-pregnant 
women: 
2 - 29 
• Pregnant women: 
10 - 209
ng/mL Electrochemiluminescency Elecsys 2010 Roche HITACHI
T4 8 4.5-12.5 µg/dL Electrochemiluminescency Elecsys 2010 Roche HITACHI
T3 132 Adults: 0.8 - 2.0  ng/ml Electrochemiluminescency Elecsys 2010 Roche HITACHI
TSH 2.5 0.5 - 4.70 mIU/L Electrochemiluminescency Elecsys 2010 Roche HITACHI
Figure 1. Pathologic finding: pleomorphism with large nuclei and vesicular 
nuclei (marked). The cells of the latter showed mild atypia characterized by 
vesicular nuclei with mild nuclear pleomorphism and enlargement, small 
nuclei and pale eosinophilic cytoplasm. No ductuloinsular complexes was 
identified in multiple sections examined.
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Then a laparoscopic pancreatectomy of about 85% of 
the pancreas was performed (Figure 2). The patient was 
positioned supine, legs apart, with the surgeon standing 
between the patient’s legs. The camera holder was on 
the patient’s right side and the surgeon’s  assistant on 
the patient’s left side. The first trocar was placed into 
the abdomen above the umbilicus, with open tech-
nique, and a 12-mm-trocar about 7 cm at the umbilical 
level on the left side of the abdomen. One 5-mm-tro-
car was inserted 5 cm on the anterior axillary line, one 
5-mm-trocar on the mid-clavicular line on the patient’s 
right side, and the last 5-mm-trocar on the epigastrium. 
A 5-mm-ligasure was used for dissection and the 
gastrocolic meso was first cut to enter the lesser sac. 
There was no evidence of mass on pancreatic surface. 
The pancreas was examined with intraoperative laparo-
scopic ultrasonography, which detected no adenoma. 
A biopsy was taken from body of pancreas and sent 
for frozen section, which confirmed PHHI. So, pan-
createctomy was scheduled for this case. The midcolic 
vein was found and followed to its entrance beneath 
the pancreas neck and was then dissected beneath it 
along the superior mesenteric vein until the superior 
border of the pancreas. Then the neck was transected 
with a purple EndoGIA tri-stapler, and the body and 
tail of the pancreas was dissected from its attachments, 
preserving the splenic artery and vein. After distal pan-
createctomy, a corrugated silicone drain was positioned 
in place. 
The patient’s postoperational general condition was 
good with no complications. The drain was removed 
five days after the operation. Postsurgical follow-up for 
two years showed a normo-glycemic state and no oc-
currence of diabetes mellitus.
DISCUSSION
Minimally invasive surgical techniques have previously 
been used in other hyperinsulinemic statuses, like in-
sulinomas (9,10). The medical group chose this tech-
nique as a result of the patient’s poor drug compliance, 
which helped him avoid receiving a more invasive inter-
vention than needed.
Although medical therapy in combination with fre-
quent enteral feeding (11) is the first choice for treat-
ment of hyperinsulinemia (12), the response varies 
widely on clinical subtypes of PHHI, categorized by 
hyperinsulinemia severity and types of genetic muta-
tions causing hypersecretion of insulin (12,13). The 
risk of hypoglycemic attacks will also rise by increasing 
the feeding intervals; and as long as older children eat 
three separate meals, they will be more predisposed to 
hypoglycemia between the meals; therefore drug thera-
py will be less effective in controlling blood sugar with 
increasing age. On the other hand, older children have 
less drug compliance, as they may feel ashamed to use 
drugs in school or in front of their friends, or might 
resist doctor’s visits, which may altogether cause poorer 
quality of life for them (14).
Additionally, the response rate of diazoxide, as the 
cornerstone of drug therapy, is partial and depends on 
many factors (15). Prevalent complications, such as 
hypertrichosis, have also been proposed for diazoxide. 
Serious complications including pulmonary hyperten-
sion, heart failure and neutropenia (16), hepatomegaly, 
severe fluid retention, diffuse edema, congestive heart 
failure, and respiratory failure requiring mechani-
cal ventilation (17) have also been reported. Another 
problem that exists in our country is the fact that di-
azoxide is not always available, due to sanctions.
Studies have assessed the efficacy of various surgical 
procedures on this rare disease, but few have investigat-
ed the minimally invasive approaches. Al-Shanafey and 
cols. performed laparoscopic pancreatectomy for infancy 
with a median of 90% extent of resection and revealed 
many advantages for this procedure including accurate 
visualization, shorter hospitalization, less postoperative 
pain, early feeding, and good cosmetic results (18). One 
year later, he compared ten laparoscopic pancreatecto-
mies with open procedure and concluded that the open 
group needs a higher extent of resection and the laparo-
scopic group is able to have earlier feeding (19). 
Berends and cols. introduced conventional intraop-
erative ultrasonography combined with contact ultra-
sonography for better localization of insulinoma (20). 
Figure 2. The laparoscopic procedure: There was no evidence of mass on 
pancreatic surface.
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Because of the small size of the adenomas, radio-
logic imaging studies often fail to localize them. Ii-
hara and Obara proposed better laparoscopic resection 
of insulinoma when located in the body or tail of the 
pancreas (21). Intra-operative frozen section biopsy, 
requiring less extended pancreatectomy, has been 
proven to play an essential role in identifying cases of 
adenoma (22). 
The accurate extent of pancreatectomy serves as a 
pitfall for surgeons, as it may induce diabetes or recur-
rent hypoglycemia (23). Ninety-five percent pancre-
atectomy is more challenging with more risk of bleed-
ing due to the high risk of dissection and ligation of 
fragile venous branches between superior mesenteric, 
portal vein and head of pancreas Our surgical team 
took an intraoperative specimen for frozen section, and 
performed 85% pancreatectomy to decrease the possi-
bility of diabetes mellitus, as 95% has a higher risk of 
diabetes mellitus. The patient is also still in a normo-
glycemic state, two years after the surgery.
Few studies have followed up with patients after 
the procedure. On the other hand, the laparoscopic 
approach we performed has rarely been used for this 
diagnosis. Its major advantages include better visualiza-
tion and localization of the mass. An interesting point 
of this case can also be minimal neurological damage 
contrary to delayed patient treatment.
In conclusion, minimally invasive pancreatectomy is 
a good choice for the diagnosis and treatment of hyper-
insulinemic hypoglycemia, with better visualization and 
a less invasive procedure to avoid unnecessary extensive 
morbidities.
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